202 related articles for article (PubMed ID: 8751893)
1. Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha.
Larsson C; Stålhammar-Carlemalm M; Lindahl G
Infect Immun; 1996 Sep; 64(9):3518-23. PubMed ID: 8751893
[TBL] [Abstract][Full Text] [Related]
2. Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections.
Stålhammar-Carlemalm M; Stenberg L; Lindahl G
J Exp Med; 1993 Jun; 177(6):1593-603. PubMed ID: 8496678
[TBL] [Abstract][Full Text] [Related]
3. Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine.
Larsson C; Stålhammar-Carlemalm M; Lindahl G
Vaccine; 1999 Feb; 17(5):454-8. PubMed ID: 10073723
[TBL] [Abstract][Full Text] [Related]
4. Intranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infection.
Larsson C; Holmgren J; Lindahl G; Bergquist C
Infect Immun; 2004 Feb; 72(2):1184-7. PubMed ID: 14742572
[TBL] [Abstract][Full Text] [Related]
5. Group B streptococcal surface proteins as targets for protective antibodies: identification of two novel proteins in strains of serotype V.
Areschoug T; Stålhammar-Carlemalm M; Larsson C; Lindahl G
Infect Immun; 1999 Dec; 67(12):6350-7. PubMed ID: 10569749
[TBL] [Abstract][Full Text] [Related]
6. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.
Gravekamp C; Kasper DL; Paoletti LC; Madoff LC
Infect Immun; 1999 May; 67(5):2491-6. PubMed ID: 10225912
[TBL] [Abstract][Full Text] [Related]
7. Cross-protection between group A and group B streptococci due to cross-reacting surface proteins.
Stâlhammar-Carlemalm M; Areschoug T; Larsson C; Lindahl G
J Infect Dis; 2000 Jul; 182(1):142-9. PubMed ID: 10882591
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with highly purified cell surface proteins confers protection against experimental group B streptococcal infection.
Larsson C; Stålhammar-Carlemalm M; Lindahl G
Adv Exp Med Biol; 1997; 418():851-3. PubMed ID: 9331786
[No Abstract] [Full Text] [Related]
9. Association between low concentrations of antibodies to protein alpha and Rib and invasive neonatal group B streptococcal infection.
Larsson C; Lindroth M; Nordin P; Stålhammar-Carlemalm M; Lindahl G; Krantz I
Arch Dis Child Fetal Neonatal Ed; 2006 Nov; 91(6):F403-8. PubMed ID: 17056838
[TBL] [Abstract][Full Text] [Related]
10. Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein.
Yang HH; Mascuch SJ; Madoff LC; Paoletti LC
Clin Vaccine Immunol; 2008 Jul; 15(7):1035-41. PubMed ID: 18463225
[TBL] [Abstract][Full Text] [Related]
11. Nonimmunodominant regions are effective as building blocks in a streptococcal fusion protein vaccine.
Stålhammar-Carlemalm M; Waldemarsson J; Johnsson E; Areschoug T; Lindahl G
Cell Host Microbe; 2007 Dec; 2(6):427-34. PubMed ID: 18078694
[TBL] [Abstract][Full Text] [Related]
12. Identification of a universal Group B streptococcus vaccine by multiple genome screen.
Maione D; Margarit I; Rinaudo CD; Masignani V; Mora M; Scarselli M; Tettelin H; Brettoni C; Iacobini ET; Rosini R; D'Agostino N; Miorin L; Buccato S; Mariani M; Galli G; Nogarotto R; Nardi-Dei V; Vegni F; Fraser C; Mancuso G; Teti G; Madoff LC; Paoletti LC; Rappuoli R; Kasper DL; Telford JL; Grandi G
Science; 2005 Jul; 309(5731):148-50. PubMed ID: 15994562
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci.
Erdogan S; Fagan PK; Talay SR; Rohde M; Ferrieri P; Flores AE; Guzmán CA; Walker MJ; Chhatwal GS
Infect Immun; 2002 Feb; 70(2):803-11. PubMed ID: 11796614
[TBL] [Abstract][Full Text] [Related]
14. Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein.
Martin D; Rioux S; Gagnon E; Boyer M; Hamel J; Charland N; Brodeur BR
Infect Immun; 2002 Sep; 70(9):4897-901. PubMed ID: 12183534
[TBL] [Abstract][Full Text] [Related]
15. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.
Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R
ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
Wessels MR; Paoletti LC; Pinel J; Kasper DL
J Infect Dis; 1995 Apr; 171(4):879-84. PubMed ID: 7706814
[TBL] [Abstract][Full Text] [Related]
17. Temperature-Induced Self-Assembly of the Group B Streptococcus (GBS) Fusion Antigen GBS-NN.
Rose F; Roovers S; Fano M; Harloff-Helleberg S; Kirkensgaard JJK; Hejnaes K; Fischer P; Foged C
Mol Pharm; 2018 Jul; 15(7):2584-2593. PubMed ID: 29745668
[TBL] [Abstract][Full Text] [Related]
18. Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines.
Yang HH; Madoff LC; Guttormsen HK; Liu YD; Paoletti LC
Infect Immun; 2007 Jul; 75(7):3455-61. PubMed ID: 17470542
[TBL] [Abstract][Full Text] [Related]
19. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.
Paoletti LC; Wessels MR; Rodewald AK; Shroff AA; Jennings HJ; Kasper DL
Infect Immun; 1994 Aug; 62(8):3236-43. PubMed ID: 8039893
[TBL] [Abstract][Full Text] [Related]
20. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.
Madoff LC; Paoletti LC; Tai JY; Kasper DL
J Clin Invest; 1994 Jul; 94(1):286-92. PubMed ID: 7518832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
